CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 45,000 shares at an average $4.50 ($202,300)
- 4 Open-market buy 10% owner bought 45,000 shares at an average $4.50 ($202,300)
- 4 Open-market buy 10% owner bought 45,000 shares at an average $4.50 ($202,300)
- 4 Open-market buy Director bought 320,290 shares at an average $4.61 ($1,477,312)
- 425 Deal Prospectus/Communication re Business Combination
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 10-K/A Report 10-K/A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Other events
- EFFECT Other Notice of Effectiveness
Page 7 of 13 · 250 filings